Sangamo Therapeutics Stock Target Price and Analyst Consensus

SGMO Stock  USD 0.62  0.02  3.33%   
The current analyst and expert consensus on Sangamo Therapeutics is Buy with 4 hold recommendations. The current projected Sangamo Therapeutics target price consensus is 6.58 with 9 analyst opinions. One of the most common ways Sangamo Therapeutics analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Sangamo Therapeutics vendors, executives, and/or customers. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Sangamo Therapeutics. We strongly encourage you to use your own analysis of Sangamo Therapeutics to validate this buy or sell advice. Sangamo Therapeutics recommendation module provides expert sentiment on the projected Sangamo Therapeutics target price to derive its highest and lowest estimates based on target price standard deviation of 0.0. Check out Macroaxis Advice on Sangamo Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Sangamo Stock, please use our How to Invest in Sangamo Therapeutics guide.
Lowest Forecast
5.99
Highest Forecast
7.3
Target Price
6.58
At this time, Sangamo Therapeutics' Gross Profit is very stable compared to the past year. As of the 28th of March 2024, Gross Profit Margin is likely to grow to 0.88, while Pretax Profit Margin is likely to drop (1.57). At this time, Sangamo Therapeutics' Accounts Payable is very stable compared to the past year. As of the 28th of March 2024, Non Currrent Assets Other is likely to grow to about 17.5 M, though Retained Earnings are likely to grow to (1.3 B).
  
It's important to approach Sangamo Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Sangamo Therapeutics price targets

Sangamo Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Sangamo Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Sangamo Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Sangamo Therapeutics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Sangamo Therapeutics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Sangamo Therapeutics is a key component of Sangamo Therapeutics valuation and have some predictive power on the future returns of a Sangamo Therapeutics.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sangamo Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.030.5712.33
Details
Intrinsic
Valuation
LowRealHigh
0.112.1013.86
Details
Naive
Forecast
LowNextHigh
0.020.7912.55
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.27-0.21-0.1
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Sangamo Therapeutics. Your research has to be compared to or analyzed against Sangamo Therapeutics' peers to derive any actionable benefits. When done correctly, Sangamo Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Sangamo Therapeutics.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Investor Favorites Idea
Investor Favorites
Invested few shares
Cash Cows Idea
Cash Cows
Invested a lot of shares
Business Services Idea
Business Services
Invested over 100 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Banking Idea
Banking
Invested over 40 shares
Hedge Favorites Idea
Hedge Favorites
Invested few shares
Momentum Idea
Momentum
Invested few shares
Machinery Idea
Machinery
Invested over 100 shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 70 shares
Millennials Best Idea
Millennials Best
Invested over 30 shares
Tech Growth Idea
Tech Growth
Invested a lot of shares
IT Idea
IT
Invested over 50 shares
Software Idea
Software
Invested few shares
Dividend Beast Idea
Dividend Beast
Invested few shares
When determining whether Sangamo Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sangamo Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sangamo Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sangamo Therapeutics Stock:
Check out Macroaxis Advice on Sangamo Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Sangamo Stock, please use our How to Invest in Sangamo Therapeutics guide.
You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Sangamo Stock analysis

When running Sangamo Therapeutics' price analysis, check to measure Sangamo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sangamo Therapeutics is operating at the current time. Most of Sangamo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sangamo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sangamo Therapeutics' price. Additionally, you may evaluate how the addition of Sangamo Therapeutics to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
The data published in Sangamo Therapeutics' official financial statements usually reflect Sangamo Therapeutics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Sangamo Therapeutics. For example, before you start analyzing numbers published by Sangamo accountants, it's critical to develop an understanding of what Sangamo Therapeutics' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Sangamo Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sangamo Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Sangamo Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sangamo Therapeutics. Please utilize our Beneish M Score to check the likelihood of Sangamo Therapeutics' management manipulating its earnings.